Noëlle Weingertner

Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors

Justine Gantzer, Guillaume Davidson, Bujamin Vokshi et al. · The Oncologist · 2022 · 61 citations · Full text

Medicine, Immunology, Oncology +17

NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker

Raul Perret, Julien Escuriol, Valérie Velasco et al. · Modern Pathology · 2020 · 58 citations · Full text

Medicine, Oncology, Pathology +14

Aggressive digital papillary adenocarcinoma: A clinicopathological study of 19 cases

Noëlle Weingertner, Anne Gressel, Maxime Battistella et al. · Journal of the American Academy of Dermatology · 2017 · 55 citations

Veterinary Medicine, Oncology, Pathology +9

Adequately defining tumor cell proportion in tissue samples for molecular testing improves interobserver reproducibility of its assessment

Benoît Lhermitte, C. Egelé, Noëlle Weingertner et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2016 · 49 citations

Medicine, Oncology, Pathology +16

Superficial CD34‐positive fibroblastic tumor and <i>PRDM10</i>‐rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases

Raul Perret, Michael Michal, Richard Carr et al. · Histopathology · 2021 · 47 citations

Medicine, Oncology, Pathology +17